You have 9 free searches left this month | for more free features.

Anemia, Hemolytic, Congenital

Showing 1 - 25 of 4,858

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral

Recruiting
  • Congenital Hemolytic Anemia
  • Sickle Cell Disease
  • Peripheral blood hematopoietic progenitor cell (PBPC) transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Pyruvate Kinase Deficiency, Pyruvate Kinase Deficiency Anemia, Anemia Trial in Worldwide

Recruiting
  • Pyruvate Kinase Deficiency
  • +3 more
    • Boston, Massachusetts
    • +4 more
    Aug 5, 2022

    Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Barcelona, Madrid (Mitapivat, Mitapivat-matching )

    Recruiting
    • Pediatric Pyruvate Kinase Deficiency
    • Pediatric Hemolytic Anemia
    • Barcelona, Spain
    • +1 more
    Aug 8, 2022

    Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Spain, United States (Mitapivat, Mitapivat-matching )

    Recruiting
    • Pediatric Pyruvate Kinase Deficiency
    • Pediatric Hemolytic Anemia
    • Phoenix, Arizona
    • +3 more
    Aug 8, 2022

    Dehydrated Hereditary Stomatocytosis Trial in Boston (Senicapoc (synonyms: ICA-17043;

    Recruiting
    • Dehydrated Hereditary Stomatocytosis
    • Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide)
    • Boston, Massachusetts
      Boston Children's Hospital
    Mar 1, 2022

    Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

    Not yet recruiting
    • Pyruvate Kinase Deficiency
    • +10 more
    • Blood Draw
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 21, 2021

    Stomatocytosis Trial in Le Kremlin Bicêtre

    Recruiting
    • Stomatocytosis
      • Le Kremlin Bicêtre, France
        AP-HP, Bicêtre Hospital, Pediatrics - Hematology - Reference cen
      Oct 28, 2021

      Parvovirus B19 Infection in Hereditary Hemolytic Anemias

      Active, not recruiting
      • Parvovirus B19 Infection
      • Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG)
      • Sohag, Egypt
        , Faculty of Medicine, Sohag University
      Mar 25, 2021

      Pyruvate Kinase Deficiency Trial in Stanford, Madrid (RP-L301)

      Recruiting
      • Pyruvate Kinase Deficiency
      • RP-L301
      • Stanford, California
      • +2 more
      Sep 22, 2021

      Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (AG-348)

      Completed
      • Pyruvate Kinase Deficiency
      • Anemia, Hemolytic
      • Oakland, California
      • +18 more
      Dec 14, 2021

      Pyruvate Kinase Deficiency Epidemiological Study (PIECE)

      Unknown status
      • Pyruvate Kinase Deficiency
        • Pembroke Pines, Florida
          Intervent Clinical Research Center
        Nov 23, 2020

        Warm Autoimmune Hemolytic Anemia Trial (Obexelimab, Placebo)

        Not yet recruiting
        • Warm Autoimmune Hemolytic Anemia
        • (no location specified)
        Mar 24, 2023

        Refractory/Relapsed Autoimmune Hemolytic Anemia Trial in Tianjin (Zanubrutinib)

        Not yet recruiting
        • Refractory/Relapsed Autoimmune Hemolytic Anemia
        • Tianjin, Tianjin, China
          Regenerative Medicine Center
        Aug 27, 2023

        Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)

        Not yet recruiting
        • Warm Autoimmune Hemolytic Anemia
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jun 21, 2023

        Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Singapore (Ianalumab, Placebo)

        Recruiting
        • Warm Autoimmune Hemolytic Anemia (wAIHA)
        • Ianalumab
        • Placebo
        • Singapore, Singapore
          Novartis Investigative Site
        Jan 5, 2023

        Autoimmune Hemolytic Anemia, Failure of Two Rounds of Treatment Trial in Zhoukou, Tianjin (Linperlisib)

        Not yet recruiting
        • Autoimmune Hemolytic Anemia
        • Failure of Two Rounds of Treatment
        • Zhoukou, Henan, China
        • +1 more
        Jan 7, 2023

        Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)

        Not yet recruiting
        • Warm Autoimmune Hemolytic Anemia
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jun 20, 2023

        Anemia, Hemolytic, Autoimmune Trial (Nipocalimab)

        Temporarily not available
        • Warm Autoimmune Hemolytic Anemia
        • (no location specified)
        Nov 15, 2022

        Pyruvate Kinase Deficiency, Anemia, Hemolytic Trial in Worldwide (Placebo, AG-348)

        Completed
        • Pyruvate Kinase Deficiency
        • Anemia, Hemolytic
        • Little Rock, Arkansas
        • +45 more
        May 20, 2022

        Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia Trial (povetacicept)

        Not yet recruiting
        • Immune Thrombocytopenia
        • +3 more
        • (no location specified)
        Mar 9, 2023

        Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

        Recruiting
        • Autoimmune Hemolytic Anemia
        • +5 more
        • cytokine essays
        • +6 more
        • Milano, Italy
          Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
        Jul 3, 2023

        Circulating Cluster of Differentiation 4 Positive 28 Null T

        Not yet recruiting
        • Autoimmune Hemolytic Anemia
          • (no location specified)
          Jan 31, 2023

          Warm Antibody Autoimmune Hemolytic Anemia Trial (HMPL-523(300mg PO QD), Placebo)

          Not yet recruiting
          • Warm Antibody Autoimmune Hemolytic Anemia
          • HMPL-523(300mg PO QD)
          • Placebo
          • (no location specified)
          Sep 7, 2022

          Hemolytic Anemia Trial in Lebanon (Daratumumab / Hyaluronidase Injection)

          Recruiting
          • Hemolytic Anemia
          • Daratumumab / Hyaluronidase Injection
          • Lebanon, New Hampshire
            Dartmouth-Hitchcock Medical Center
          Jun 15, 2022

          Warm Autoimmune Hemolytic Anemia Trial in Worldwide (RVT-1401 680 mg/weekly, RVT-1401 340 mg/weekly)

          Terminated
          • Warm Autoimmune Hemolytic Anemia
          • RVT-1401 680 mg/weekly
          • RVT-1401 340 mg/weekly
          • Iowa City, Iowa
          • +20 more
          Jul 1, 2022